Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Common noncancerous skin diseases have various treatments, including topical applications, light therapy, surgery, and medications, with psychological support being important.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Autoimmune skin disorders are caused by genetic and environmental factors and are treated with various medications and preventative strategies.

Poor nutrition can lead to skin diseases in hospitalized patients and should be quickly identified and treated.

The study suggests a link between varicella-zoster virus and segmental vitiligo, with evidence of the virus disrupting skin pigment cells.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

The link between pemphigus and the patient's scarring hair loss is still unclear.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Stress might contribute to hair loss in alopecia areata.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.